Analyses of soluble endoglin and matrix metalloproteinase 14 using enzyme-linked immunosorbent assay in the diagnosis and assessment of severity of early- and late-onset pre-eclampsia


Ovayolu A., Ovayolu G., Karaman E. , Guler S., Dogan I., Yuce T.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, vol.22, no.1, pp.29-36, 2021 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.4274/jtgga.galenos.2020.2019.0201
  • Title of Journal : JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
  • Page Numbers: pp.29-36

Abstract

Objective: Abnormal trophoblastic invasion and impaired placentation have a crucial role in the etiopathogenesis of preeclampsia (PrE). Trophoblastic cells are involved in invading the maternal decidua and remodelling of the spiral arteries with matrix metalloproteinase-14 (MMP-14). MMP-14 cleavage of endoglin releases its extracellular region, the soluble form of endoglin (s-ENG), into the maternal circulation. In PrE, there is a relationship between endothelial dysfunction and s-ENG concentration. The aim was to determine and compare the serum levels of s-ENG and MMP-14 in different groups of PrE patients and healthy subjects.